trending Market Intelligence /marketintelligence/en/news-insights/trending/8r37ptca_z1e1npwiojeea2 content esgSubNav
In This List

Moleculin to raise $9M

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Moleculin to raise $9M

Moleculin Biotech, Inc. is looking to raise $9 million via the sale of 4.29 million shares at $2.10 each.

Each share comes bundled with half of a purchase warrant. Each whole warrant can be exchanged for a stock of Moleculin Biotech for $2.80.

The Houston-based pharmaceutical company, which is developing treatments for cancer, will use funds to continue development of its product pipeline.

The offering is expected to close by Feb. 21 with Roth Capital Partners serving as sole placement agent.